Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist

Cilt: 10 Sayı: 4 1 Aralık 2013
  • Murat Acar
  • Servet Tatlı
  • Stuart G Silverman
PDF İndir
EN TR

Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist

Abstract

Leiomyomatosis peritonealis disseminata (LPD) is a rare disorder characterized by multiple subperitoneal benign smooth muscle nodules. It is usually incidentally discovered during cesarean section or laparoscopy. In this paper, we present pre-and-post GnRH treatment MRI findings of a symptomatic patient with LPD.

Keywords

Kaynakça

  1. Sharma P, Chaturvedi KU, Gupta R, Nigam S. Leiomyomatosis peritonealis disseminata with malig- nant change in a post-menopausal woman. Gynecol Oncol 2004;95: 742-5.
  2. Halama N, Grauling-Halama SA, Daboul I. Familial cluster- ing of Leiomyomatosis peritonealis disseminata: an un- known genetic syndrome? BMC Gastroenterol 2005;33: 1-5.
  3. Nappi C, Di Spiezio Sardo A, Mandato VD, et al. Leiomyomatosis peritonealis disseminata in association with Currarino syndrome? BMC Cancer 2006; 6:127. 235
  4. Papadatos D, Taourel P, Bret PM. CT of leiomyomatosis peritonealis disseminata mimicking peritoneal carcino- matosis. AJR Am J Roentgenol 1996;167: 475-6.
  5. Kokcu A, Alvur Y, Baris YS, Kuskonmaz I. Leiomyomatosis peritonealis disseminata. Acta Obstet Gynecol Scand 1994;73: 81-3.
  6. Ueda H, Togashi K, Konishi I, et al. Unusual appearances of uterine leiomyomas: MR imaging findings and their his- topathologic backgrounds. Radiographics 19: 1999;131-45.

Ayrıntılar

Birincil Dil

İngilizce

Konular

-

Bölüm

-

Yazarlar

Murat Acar Bu kişi benim

Servet Tatlı Bu kişi benim

Stuart G Silverman Bu kişi benim

Yayımlanma Tarihi

1 Aralık 2013

Gönderilme Tarihi

27 Nisan 2015

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2013 Cilt: 10 Sayı: 4

Kaynak Göster

APA
Acar, M., Tatlı, S., & Silverman, S. G. (2013). Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist. European Journal of General Medicine, 10(4). https://izlik.org/JA67YR43ER
AMA
1.Acar M, Tatlı S, Silverman SG. Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist. European Journal of General Medicine. 2013;10(4). https://izlik.org/JA67YR43ER
Chicago
Acar, Murat, Servet Tatlı, ve Stuart G Silverman. 2013. “Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist”. European Journal of General Medicine 10 (4). https://izlik.org/JA67YR43ER.
EndNote
Acar M, Tatlı S, Silverman SG (01 Aralık 2013) Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist. European Journal of General Medicine 10 4
IEEE
[1]M. Acar, S. Tatlı, ve S. G. Silverman, “Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist”, European Journal of General Medicine, c. 10, sy 4, Ara. 2013, [çevrimiçi]. Erişim adresi: https://izlik.org/JA67YR43ER
ISNAD
Acar, Murat - Tatlı, Servet - Silverman, Stuart G. “Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist”. European Journal of General Medicine 10/4 (01 Aralık 2013). https://izlik.org/JA67YR43ER.
JAMA
1.Acar M, Tatlı S, Silverman SG. Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist. European Journal of General Medicine. 2013;10. Available at https://izlik.org/JA67YR43ER.
MLA
Acar, Murat, vd. “Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist”. European Journal of General Medicine, c. 10, sy 4, Aralık 2013, https://izlik.org/JA67YR43ER.
Vancouver
1.Murat Acar, Servet Tatlı, Stuart G Silverman. Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist. European Journal of General Medicine [Internet]. 01 Aralık 2013;10(4). Erişim adresi: https://izlik.org/JA67YR43ER